Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.

[1]  Jorge A. Garcia,et al.  Complications of androgen deprivation therapy in prostate cancer. , 2009, Current opinion in urology.

[2]  T. Badger,et al.  Body image perceptions in men with prostate cancer. , 2009, Oncology nursing forum.

[3]  T. Badger,et al.  Body Image and Quality of Life in Men With Prostate Cancer , 2009, Cancer nursing.

[4]  Michel Bolla,et al.  [EAU guidelines on prostate cancer]. , 2009, Actas urologicas espanolas.

[5]  Daniel J. Buysse,et al.  Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications , 2008, Dialogues in clinical neuroscience.

[6]  S. Tufik,et al.  The effects of testosterone on sleep and sleep-disordered breathing in men: its bidirectional interaction with erectile function. , 2008, Sleep medicine reviews.

[7]  Hui Lin,et al.  Predictors of sleep quality in women in the menopausal transition. , 2008, Sleep.

[8]  P. Muennig,et al.  I think therefore I am: perceived ideal weight as a determinant of health. , 2008, American journal of public health.

[9]  Dieter Riemann,et al.  Insomnia and comorbid psychiatric disorders. , 2007, Sleep medicine.

[10]  A. D'Amico,et al.  Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. , 2007, Journal of the National Cancer Institute.

[11]  N. Frasure-smith,et al.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. , 2007, JAMA.

[12]  I. Tannock,et al.  Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. , 2006, The Journal of urology.

[13]  J. Goodwin,et al.  Risk of the "androgen deprivation syndrome" in men receiving androgen deprivation for prostate cancer. , 2006, Archives of internal medicine.

[14]  S. Sereika,et al.  Quality of Life in Prostate Cancer Patients Taking Androgen Deprivation Therapy , 2006, Journal of the American Geriatrics Society.

[15]  G. Debonnel,et al.  Oestrogen and Testosterone Modulate the Firing Activity of Dorsal Raphe Nucleus Serotonergic Neurones in Both Male and Female Rats , 2005, Journal of neuroendocrinology.

[16]  L. Lacombe,et al.  Insomnia in men treated with radical prostatectomy for prostate cancer , 2005, Psycho-oncology.

[17]  D. Kivlahan,et al.  Low testosterone levels predict incident depressive illness in older men: effects of age and medical morbidity. , 2005, The Journal of clinical psychiatry.

[18]  F. Desgrandchamps.  Who will benefit from combination therapy? The role of 5 alpha reductase inhibitors and alpha blockade: a reflection from MTOPS , 2004, Current opinion in urology.

[19]  L. Parvinen,et al.  Androgen deprivation and cognition in prostate cancer , 2003, British Journal of Cancer.

[20]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[21]  W. E. Barnes,et al.  Testosterone treatment enhances regional brain perfusion in hypogonadal men. , 2003, The Journal of clinical endocrinology and metabolism.

[22]  P. Scardino,et al.  National Comprehensive Cancer Network guidelines for the management of prostate cancer. , 2003, Urology.

[23]  W. Yates,et al.  Testosterone therapy in late-life major depression in males. , 2002, The Journal of clinical psychiatry.

[24]  W. Pirl,et al.  Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot Study , 2002, Psycho-oncology.

[25]  R. Gardiner,et al.  Altered cognitive function in men treated for prostate cancer with luteinizing hormone‐releasing hormone analogues and cyproterone acetate: a randomized controlled trial , 2002, BJU international.

[26]  S. Cerutti,et al.  Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. , 2002, The Journal of urology.

[27]  J. Stanford,et al.  Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. , 2002, Journal of the National Cancer Institute.

[28]  Anthony L Zietman,et al.  Changes in body composition during androgen deprivation therapy for prostate cancer. , 2002, The Journal of clinical endocrinology and metabolism.

[29]  P. Costanzo,et al.  Body image partially mediates the relationship between obesity and psychological distress. , 2002, Obesity research.

[30]  Mathias Berger,et al.  Sleep and depression — results from psychobiological studies: an overview , 2001, Biological Psychology.

[31]  J Berger,et al.  Symptomatic and syndromal anxiety and depression , 2001, Depression and anxiety.

[32]  Penny Hopwood,et al.  A body image scale for use with cancer patients. , 2001, European journal of cancer.

[33]  P. Walsh.  Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. , 2000, The Journal of urology.

[34]  G. Fink,et al.  Androgen actions on central serotonin neurotransmission: relevance for mood, mental state and memory , 1999, Behavioural Brain Research.

[35]  I. Heuser,et al.  Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. , 1999, Psychosomatic medicine.

[36]  E. Barrett-Connor,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Bioavailable Testosterone and Depressed Mood in Older Men: The Rancho Bernardo Study , 2022 .

[37]  W. Sause,et al.  Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31). Radiation Therapy Oncology Group. , 1998, International journal of radiation oncology, biology, physics.

[38]  K. Pienta,et al.  Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. , 1997, Urology.

[39]  R. Swerdloff,et al.  Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. , 1996, The Journal of clinical endocrinology and metabolism.

[40]  W. Sause,et al.  Androgen suppression plus radiation versus radiation alone for patients with D1 (pN+) adenocarcinoma of the prostate (results based on a national prospective randomized trial, RTOG 85-31) , 1996 .

[41]  S. Fosså,et al.  Quality of life in prostate cancer , 1992, The Prostate. Supplement.

[42]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[43]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.